Lifestyle and clinical health behaviors and psa tests

American Journal of Health Education

Volumn 37, Issue 5, 2006, Pages 289-295

  Norris, Cynthia G ^a   McFall, Stephanie ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947195882     PISSN: 19325037     EISSN: 21683751     Source Type: Journal    
DOI: 10.1080/19325037.2006.10598917     Document Type: Article

References (32)

1. Jemal A, Tiwari R, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA— Cancer J Clin. 2004;54:8-29.
2. American Cancer Society. Cancer Facts & Figures 2006. Atlanta, GA: American Cancer Society; 2006.
3. Harris R, Lohr KN. Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Internal Med. 2002;137:917-929.
4. American College of Physicians. Screening for prostate cancer. Ann Intern Med. 1997;126(6):480-484.
5. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology (Huntington). 2000;14(2):267-272, 277-268, 280.
6. Smith RA, Mettlin CJ, Davis KJ, Eyre H. Am Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000;50 (1):34-49.
7. Berrigan D, Dodd K, Toioiano RP, KrebsSmith SM, Barbash RB. Patterns of health behavior in U.S. adults. Prev Med. 2003;36: 615-623.
8. Liang W, Shediac-Rizkallah MC, Celentano DG, Rohde C. A population-based study of age and gender differences in patterns of health-related behaviors. Am J Prev Med. 1999;17(1):8-17.
9. Patterson RE, Haines PS, Popkin BM. Health lifestyle patterns of U.S. adults. Prev Med. 1994;23(4):453-460.
10. Pronk NP, Anderson LH, Crain AL, Martinson BC, et al. Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med. 2004;27:25-33.
11. Fredman L, Sexton M, Cui Y, Althuis M, et al. Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older. Prev Med. 1999;28:407-417.
12. Pearlman DN, Rakowski W. Breast cancer screening practices among black, Hispanic and white Women: Reassessing differences. Am J Prev Med. 1996;12(5):327-337.
13. Rakowski W, Clark MA, Ehrich B. Smoking and cancer screening for women ages 4275: associations in the 1990-1994 National Health Interview Surveys. Prev Med. 1999;29:487-495.
14. Rakowski W, Rimer BK, Bryant SA. Integrating behavior and intention regarding mammography by respondents in the 1990 National Health Interview Survey of Health Promotion and Disease Prevention. Public Health Rep. 993;108(5):605-624.
15. U.S Centers for Disease Control and Prevention. Screening with the prostate-specific antigen test—Texas, 1997. Morb Mortal Wkly Rep. 2000;49(36):818-820.
16. Close DR, Kristal AR, Li S, Patterson RE, et al. Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Cancer Epidemiol Biomarkers Prev. 1998;7(July):627-630.
17. Hoffman RM, Gilliland FD. A population-based survey of prostate cancer testing in New Mexico. J Community Health. 1999;24(6):409-419.
18. Merrill RM. Demographic and health-related factors of men receiving prostate-specific antigen screening in Utah. Prev Med. 2001;33:646-652.
19. Ross LE, Coates RC, Breen N, Uhler RJ, et al. Prostate-specific antigen test use reported in the National Health Interview Survey. Prev Med. 2004;38:732-744.
20. Rutten LJF, Meissner HI, Breen N, Vernon SW, et al. Factors associated with men’s use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med. 2005;40:461-468.
21. Steele CB, Miller DS, Maylahn C, Uhler RJ, et al. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am JPublic Health. 2000;90(10): 1595-1600.
22. U.S. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey data. Atlanta: U.S. Centers for Disease Control and Prevention; 2003.
23. Holtzman D. Analysis and interpretations of data from the U.S. Behavioral Risk Factor Surveillance System. In: McQueen DV, Puska P, eds. Global Behavioral Risk Factor Surveillance. New York: Kluwer Academic/Plenum Publishers; 2003. p. 35-46.
24. U.S. Centers for Disease Control and Prevention. 2002Behavioral Risk Factor Surveillance System Summary Data Quality Report. Atlanta: U.S. Centers for Disease Control and Prevention; 2003.
25. American Cancer Society. Cancer facts & figures 2004. Atlanta: American Cancer Society; 2004.
26. Canto MT, Chu KC. Annual cancer incidence rates for Hispanics in the United States. Surveillance, Epidemiology, and End Results, 1992-1996. Cancer. 2000;88:2642-2652.
27. Cotter MP, Gern RW, Ho GYF, Chang RY, et al. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 2002;50:216-221.
28. Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, et al. Prostate cancer: Demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina. Urology. 1999;53:1194-1199.
29. Chan EC, Vernon SW, Ahn C, Greisinger A. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at two sites. Am J Public Health. 2004;94(8):1336-1338.
30. Volk RJ, Cass AR. The accuracy of pri-mary care patients’ self-reports of prostate-specific antigen testing. Am J Prev Med. 2002;22(l):56-58.
31. Jordan TR, Price JH, King KA, Masyk T, et al. The validity of male patients’ self-reports regarding prostate cancer screening. Prev Med. 1999;28:297-303.
32. Briss P, Rimer B, Reilly B, Coates RC, et al. Promoting informed decision about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26(1):67-80.